Ainos Announces Zacks SCR Publishes New Article Discussing Ainos' Healthcare Infrastructure Study At National Taiwan University Hospital
Ainos Q1 EPS $(0.41) Up From $(1.05) YoY, Sales $161.000 Down From $106.207K YoY
Ainos Highlights Continued Expansion Of Its Smell AI Deployments
Ainos Q4 EPS $(0.85) Up From $(1.30) YoY, Sales $11.120K
Ainos Activates Phased Industrial Deployment Roadmap To Install Up To 20K AI Nose Units
Ainos shares are trading lower. The company announced interim results from its ongoing multi-dose clinical trial evaluating VELDONA for the treatment of Feline Chronic Gingivostomatitis.
Water Tower Research Highlights Mirle Partnership Fueling Ainos' Robotics Scale-Up and SmellTech Expansion
Ainos' SmellTech Platform Scales Up With Mirle Partnership, Integrating AI Nose For Advanced Robotics In Industrial Settings
Water Tower Research Fireside Chat with Ainos: AI Nose Powering SmellTech Expansion and Scalable Value Creation
Ainos shares are trading higher after the company announced a technology partnership with Mirle Automation to integrate Ainos' AI Nose platform into robots and quadruped robots.
Ainos and Mirle Automation Partner to Bring Scent Intelligence to Robots and Quadruped Robots
Ainos to Participate in Fireside Chat with Water Tower Research on January 26, 2026
Water Tower Research Highlights Ainos SmellTech's Rising Commercial Momentum in Scalable AI Infrastructure Platform Shift
Ainos Announces Distribution Partnership with Trusval Technology to Expand AI Nose into Semiconductor Front-End Manufacturing
Ainos And Trusval Technology Agree To Establish Distribution And Deployment Partnership Within Defined Scope Of Semiconductor Front-End Manufacturing Applications
Ainos Articulates Its Platform Strategy to Digitize Smell as the Next Native AI Data Language
Ainos to Relocate U.S. Headquarters to Houston, Texas; Forms ScentAI Inc.
Ainos Reports Third Quarter 2025 Financial Results
Ainos Q3 EPS $(0.64) Up From $(1.65) YoY, Sales $2.167K
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.